Patent Assignment
Reel/Frame 057836/0286
Change of Address
Recorded: 2021-10-06
Pages: 7
Assignor
RHIZEN PHARMACEUTICALS AG
Executed: 2021-09-14
Assignee
RHIZEN PHARMACEUTICALS AG
GROSSPETERTOWER, GROSSPETERANLAGE 29, BASEL, 4052, SWITZERLAND
Covered Properties
(63)
Novel Kinase Modulators
Novel Compounds as Modulators of Protein Kinases
Application:
17/301,841 →
Publication:
US US20210401840A1
Process for Preparation of Optically Pure and Optionally Substituted 2-(1-Hydroxy-Alkyl)-Chromen-4-One Derivatives and Their Use in Preparing Pharmaceuticals
Novel Selective PI3K Delta Inhibitors
Application:
17/220,806 →
Publication:
US US20210403475A1
Novel 3,5-Disubstituted-3H-Imidazo[4,5-B]Pyridine and 3,5- Disubstituted -3H-[1,2,3]Triazolo[4,5-B] Pyridine Compounds as Modulators of C-Met Protein Kinases
Application:
17/303,494 →
Publication:
US US20210371416A1
Dual Selective PI3 Delta and Gamma Kinase Inhibitors
PI3K Protein Kinase Inhibitors
Novel Glutaminase Inhibitors
Application:
16/825,755 →
Publication:
US US20210032236A1
Inhibitors of Glutaminase
Application:
14/769,365 →
Publication:
US US20160297761A1
Forms of a PI3K Delta Selective Inhibitor for Use in Pharmaceutical Formulations
Application:
17/247,806 →
Publication:
US US20210269446A1
Selective Dual Inhibitors of PI3 Delta and Gamma Protein Kinases
Application:
16/810,219 →
Publication:
US US20200199133A1
Method of Treatment and Compositions Comprising a Dual P13K Delta-Gamma Kinase Inhibitor and a Corticosteroid
Application:
16/999,825 →
Publication:
US US20210030757A1
Calcium Release-Activated Calcium Channel Modulators for Treating Hematological and Solid Cancers
Application:
16/759,629 →
Publication:
US US20200281918A1
Composition and Method for Treating Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
Application:
16/762,870 →
Publication:
US US20200289520A1
Compositions Comprising a Crac Inhibitor and a Corticosteroid and Methods of Use Thereof
Application:
17/250,864 →
Publication:
US US20220040162A1
2,3-Disubstituted Chromen-4-One Compounds as Modulators of Protein Kinases
4H-Chromen-4-One Compounds as Modulators of Protein Kinases
Substituted Chromenes as Kinase Modulators
Novel Kinase Modulators
Novel Kinase Modulators
Novel Modulators of Calcium Release-Activated Calcium Channel
Novel Modulators of Calcium Release-Activated Calcium Channel
Novel Modulators of Calcium Release-Activated Calcium Channel
Novel Modulators of Calcium Release-Activated Calcium Channel
Novel Modulators of Calcium Release-Activated Calcium Channel
Novel Modulators of Calcium Release-Activated Calcium Channel
Novel Modulators of Calcium Release-Activated Calcium Channel and Methods for Treatment of Non-Small Cell Lung Cancer
Novel Modulators of Calcium Release-Activated Calcium Channel and Methods for Treatment of Non-Small Cell Lung Cancer
Novel Immunomodulator and Anti-Inflammatory Compounds
Novel Immunomodulator and Anti-Inflammatory Compounds
Novel 3,5-Disubstituted-3H-Imidazo[4,5-B]Pyridine and 3,5- Disubstituted -3H-[1,2,3]Triazolo[4,5-B] Pyridine Compounds as Modulators of Protein Kinases
Novel 3,5-Disubstituted-3H-Imidazo[4,5-B]Pyridine and 3,5-Disubstituted -3H-[1,2,3]Triazolo[4,5-B] Pyridine Compounds as Modulators of Protein Kinases
Novel 3,5-Disubstituted-3H-Imidazo[4,5-B]Pyridine and 3,5-Disubstituted-3H-[1,2,3]Triazolo[4,5-B] Pyridine Compounds as Modulators of Protein Kinases
Novel 3,5-Disubstituted-3H-Imidazo[4,5-B]Pyridine and 3,5-Disubstituted -3H-[1,2,3]Triazolo[4,5-B] Pyridine Compounds as Modulators of Protein Kinases
Bicyclic Compounds as Modulators of Gpr-119
Novel Compounds as Modulators of Protein Kinases
Novel Compounds as Modulators of Protein Kinases
Patent:
10,220,035 →
Application:
14/750,953 →
Substituted Chromenones as Modulators of Protein Kinases
Intermediates Useful in the Synthesis of Compounds as Modulators of Protein Kinases
Novel Process for Preparation of Optically Pure and Optionally Substituted 2-(1-Hydroxy-Alkyl)-Chromen-4-One Derivatives and Their Use in Preparing Pharmaceuticals
Process for Preparation of Optically Pure and Optionally Substituted 2-(1-Hydroxy-Alkyl)-Chromen-4-One Derivatives and Their Use in Preparing Pharmaceuticals
Novel Selective PI3K Delta Inhibitors
Novel Selective PI3K Delta Inhibitors
Novel Selective PI3K Delta Inhibitors
Novel Selective PI3K Delta Inhibitors
Novel Selective PI3K Delta Inhibitors
Novel Selective PI3K Delta Inhibitors
Novel 3,5-Disubstituted-3H-Imidazo[4,5-B]Pyridine and 3,5-Disubstituted-3H-[1,2,3]Triazolo[4,5-B] Pyridine Compounds as Modulators of C-Met Protein Kinases
Novel 3,5-Disubstituted-3H-Imidazo[4,5-B]Pyridine and 3,5-Disubstituted-3H-[1,2,3]Triazolo[4,5-B] Pyridine Compounds as Modulators of C-Met Protein Kinases
Pharmaceutical Compositions Containing a PDE4 Inhibitor and a PI3 Delta or Dual PI3 Delta-Gamma Kinase Inhibitor
Pharmaceutical Compositions Containing a PDE4 Inhibitor and a PI3 Delta or Dual PI3 Delta-Gamma Kinase Inhibitor
Pharmaceutical Compositions Containing a PDE4 Inhibitor and a PI3 Delta or Dual PI3 Delta-Gamma Kinase Inhibitor
Pharmaceutical Compositions Containing a PDE4 Inhibitor and a P13 Delta or Dual P13 Delta-Gamma Kinase Inhibitor
Dual Selective PI3 Delta and Gamma Kinase Inhibitors
Dual Selective PI3 Delta and Gamma Kinase Inhibitors
Novel Glutaminase Inhibitors
Novel Glutaminase Inhibitors
Improved Forms of a PI3K Delta Selective Inhibitor for Use in Pharmaceutical Formulations
Forms of a PI3K Delta Selective Inhibitor for Use in Pharmaceutical Formulations
Forms of a PI3K Delta Selective Inhibitor for Use in Pharmaceutical Formulations
Selective Dual Inhibitors of PI3 Delta and Gamma Protein Kinases
Selective Dual Inhibitors of PI3 Delta and Gamma Protein Kinases
Method of Treatment and Compositions Comprising a Dual PI3K Delta-Gamma Kinase Inhibitor and a Corticosteroid
Related Assignments
(14)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 28, 2010
From: MUTHUPPALANIAPPAN, MEYYAPPAN; VISWANADHA, SRIKANT; MERIKAPUDI, GAYATRI S
To: INCOZEN THERAPEUTICS PVT. LTD.
Reel/Frame 025210/0960 →
Assignment of Assignor's Interest
Oct 28, 2010
From: VAKKALANKA, SWAROOP KUMAR V.S.
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 025211/0107 →
Assignment of Assignor's Interest
Jan 19, 2011
From: VAKKALANKA, SWAROOP KUMAR V.S.
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 025663/0447 →
Assignment of Assignor's Interest
Jan 19, 2011
From: MUTHUPPALANIAPPAN, MEYYAPPAN; VISWANADHA, SRIKANT; BABU, GOVINDARAJULU
To: INCOZEN THERAPEUTICS PVT. LTD.
Reel/Frame 025663/0420 →
Assignment of Assignor's Interest
Mar 26, 2012
From: INCOZEN THERAPEUTICS PVT. LTD.
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 027928/0920 →
Assignment of Assignor's Interest
Oct 19, 2015
From: BHAVAR, PRASHANT K; VAKKALANKA, SWAROOP K; VISWANADHA, SRIKANT; MERIKAPUDI, GAYATRI S
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 036824/0057 →
Assignment of Assignor's Interest
Feb 16, 2016
From: BHAVAR, PRASHANT K; VAKKALANKA, SWAROOP K; BABU, GOVINDARAJULU
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 037745/0334 →
Assignment of Assignor's Interest
Aug 6, 2020
From: VISWANADHA, SRIKANT; VAKKALANKA, SWAROOP KUMAR VENKATA SATYA
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 053422/0677 →
Assignment of Assignor's Interest
Dec 15, 2020
From: VAKKALANKA, SWAROOP KUMAR VENKATA SATYA
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 054646/0855 →
Change of Address
Mar 22, 2021
From: RHIZEN PHARMACEUTICALS SA
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 056775/0375 →
Assignment of Assignor's Interest
Mar 26, 2021
From: VISWANADHA, SRIKANT; VAKKALANKA, SWAROOP KUMAR VENKATA SATYA
To: RHIZEN PHARMACEUTICALS AG
Reel/Frame 055738/0508 →
Assignment of Assignor's Interest
Nov 13, 2023
From: MUTHUPPALANIAPPAN, MEYYAPPAN; VISWANADHA, SRIKANT; BABU, GOVINDARAJULU
To: INCOZEN THERAPEUTICS PVT. LTD.
Reel/Frame 065546/0453 →
Assignment of Assignor's Interest
Nov 13, 2023
From: VAKKALANKA, SWAROOP KUMAR V.S.
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 065546/0506 →
Assignment of Assignor's Interest
Nov 13, 2023
From: INCOZEN THERAPEUTICS PVT. LTD.
To: RHIZEN PHARMACEUTICALS AG
Reel/Frame 065546/0582 →